Heron Therapeutics (HRTX) Competitors $2.14 +0.03 (+1.18%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock HRTX vs. AUPH, CVAC, MLYS, PAHC, RCUS, WVE, SNDX, COLL, ELVN, and SYREShould you be buying Heron Therapeutics stock or one of its competitors? The main competitors of Heron Therapeutics include Aurinia Pharmaceuticals (AUPH), CureVac (CVAC), Mineralys Therapeutics (MLYS), Phibro Animal Health (PAHC), Arcus Biosciences (RCUS), Wave Life Sciences (WVE), Syndax Pharmaceuticals (SNDX), Collegium Pharmaceutical (COLL), Enliven Therapeutics (ELVN), and Spyre Therapeutics (SYRE). These companies are all part of the "pharmaceutical products" industry. Heron Therapeutics vs. Aurinia Pharmaceuticals CureVac Mineralys Therapeutics Phibro Animal Health Arcus Biosciences Wave Life Sciences Syndax Pharmaceuticals Collegium Pharmaceutical Enliven Therapeutics Spyre Therapeutics Heron Therapeutics (NASDAQ:HRTX) and Aurinia Pharmaceuticals (NASDAQ:AUPH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations. Do analysts recommend HRTX or AUPH? Heron Therapeutics currently has a consensus price target of $5.67, indicating a potential upside of 167.30%. Aurinia Pharmaceuticals has a consensus price target of $11.50, indicating a potential upside of 41.10%. Given Heron Therapeutics' higher probable upside, research analysts plainly believe Heron Therapeutics is more favorable than Aurinia Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heron Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00Aurinia Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, HRTX or AUPH? Heron Therapeutics has a beta of 1.16, indicating that its stock price is 16% more volatile than the S&P 500. Comparatively, Aurinia Pharmaceuticals has a beta of 1.15, indicating that its stock price is 15% more volatile than the S&P 500. Does the MarketBeat Community believe in HRTX or AUPH? Heron Therapeutics received 93 more outperform votes than Aurinia Pharmaceuticals when rated by MarketBeat users. However, 73.41% of users gave Aurinia Pharmaceuticals an outperform vote while only 68.86% of users gave Heron Therapeutics an outperform vote. CompanyUnderperformOutperformHeron TherapeuticsOutperform Votes67068.86% Underperform Votes30331.14% Aurinia PharmaceuticalsOutperform Votes57773.41% Underperform Votes20926.59% Do insiders & institutionals have more ownership in HRTX or AUPH? 80.0% of Heron Therapeutics shares are held by institutional investors. Comparatively, 36.8% of Aurinia Pharmaceuticals shares are held by institutional investors. 5.9% of Heron Therapeutics shares are held by insiders. Comparatively, 12.2% of Aurinia Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media refer more to HRTX or AUPH? In the previous week, Heron Therapeutics had 4 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 11 mentions for Heron Therapeutics and 7 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 1.63 beat Heron Therapeutics' score of 1.06 indicating that Aurinia Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heron Therapeutics 4 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aurinia Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Is HRTX or AUPH more profitable? Aurinia Pharmaceuticals has a net margin of -10.23% compared to Heron Therapeutics' net margin of -20.31%. Heron Therapeutics' return on equity of 0.00% beat Aurinia Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Heron Therapeutics-20.31% N/A -12.72% Aurinia Pharmaceuticals -10.23%-4.41%-3.07% Which has higher valuation and earnings, HRTX or AUPH? Aurinia Pharmaceuticals has higher revenue and earnings than Heron Therapeutics. Heron Therapeutics is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeron Therapeutics$148.52M2.18-$110.56M-$0.06-35.33Aurinia Pharmaceuticals$247.30M4.45-$78.02M$0.2829.11 SummaryAurinia Pharmaceuticals beats Heron Therapeutics on 9 of the 17 factors compared between the two stocks. Get Heron Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HRTX vs. The Competition Export to ExcelMetricHeron TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$323.44M$6.78B$5.55B$8.67BDividend YieldN/A2.49%5.27%4.19%P/E Ratio-11.788.7927.2220.17Price / Sales2.18263.83423.71161.98Price / CashN/A65.8538.2534.64Price / Book-9.226.677.134.72Net Income-$110.56M$143.49M$3.23B$247.80M7 Day Performance3.92%5.15%3.78%2.75%1 Month Performance0.47%15.42%13.34%9.70%1 Year Performance-41.76%6.02%32.21%14.51% Heron Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HRTXHeron Therapeutics3.736 of 5 stars$2.15+1.2%$5.67+164.2%-42.5%$327.25M$148.52M-11.92300News CoveragePositive NewsAnalyst ForecastAnalyst RevisionGap UpAUPHAurinia Pharmaceuticals3.2903 of 5 stars$7.96+1.5%$11.50+44.5%+50.9%$1.08B$247.30M-53.06300Positive NewsAnalyst RevisionCVACCureVac4.0935 of 5 stars$4.63+3.6%$11.00+137.6%-7.0%$1.04B$523.70M8.42880MLYSMineralys Therapeutics2.7252 of 5 stars$15.70+0.8%$38.00+142.0%+18.7%$1.02BN/A-4.3128Positive NewsAnalyst ForecastPAHCPhibro Animal Health3.6688 of 5 stars$24.58+0.7%$20.00-18.6%+43.8%$996.33M$1.19B51.211,860Positive NewsRCUSArcus Biosciences2.7521 of 5 stars$9.21+3.1%$25.67+178.8%-37.7%$974.67M$141M-2.92500Analyst RevisionGap UpWVEWave Life Sciences4.2896 of 5 stars$6.25+4.0%$21.17+238.7%+22.5%$963.34M$104.94M-5.63240Positive NewsAnalyst RevisionSNDXSyndax Pharmaceuticals3.223 of 5 stars$10.98+4.2%$35.91+227.0%-43.0%$944.80M$43.72M-3.02110Positive NewsCOLLCollegium Pharmaceutical3.8755 of 5 stars$29.31+0.6%$43.80+49.4%-8.8%$941.79M$664.28M12.63210Positive NewsELVNEnliven Therapeutics2.707 of 5 stars$19.14+7.7%$37.25+94.6%-3.9%$939.18MN/A-10.0750SYRESpyre Therapeutics2.2677 of 5 stars$15.40+0.8%$53.40+246.8%-49.1%$928.25M$890,000.00-2.0673 Related Companies and Tools Related Companies Aurinia Pharmaceuticals Competitors CureVac Competitors Mineralys Therapeutics Competitors Phibro Animal Health Competitors Arcus Biosciences Competitors Wave Life Sciences Competitors Syndax Pharmaceuticals Competitors Collegium Pharmaceutical Competitors Enliven Therapeutics Competitors Spyre Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HRTX) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heron Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heron Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
